ALLERGIKLINIKKEN ApS Financials, key figures and credit report
Gross profit -27.2 kDKK FY 2025 +49.6% vs 2024
EBIT - 389.8 kDKK FY 2025 -52.3% vs 2024
Net debt -3 770.0 kDKK FY 2025 +6.5% vs 2024
Quick ratio 49.5 FY 2025 -207.4 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 2 361.01 | -75.70 | -61.92 | -53.95 | -27.17 |
| Other operating expenses | - 465.28 | - 675.02 | - 202.01 | - 362.62 | |
| EBIT | 2 361.01 | - 540.98 | - 736.94 | - 255.97 | - 389.79 |
| Other financial income | 338.96 | 216.48 | 423.21 | 37.71 | 56.47 |
| Other financial expenses | - 465.96 | - 463.06 | -0.05 | -92.19 | - 373.31 |
| Pre-tax profit | 2 234.01 | - 787.56 | - 313.78 | - 310.45 | - 706.64 |
| Income taxes | - 350.37 | 282.86 | 155.69 | 0.11 | |
| Net earnings | 1 883.65 | - 504.70 | - 158.10 | - 310.45 | - 706.53 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Land and waters | 3 700.00 | 2 900.00 | 900.79 | 600.19 | |
| Tangible assets total | 3 700.00 | 2 900.00 | 900.79 | 600.19 | |
| Investments total | |||||
| Non-curr. owed by group member comp. | 150.00 | ||||
| Long term receivables total | 150.00 | ||||
| Inventories total | |||||
| Current other receivables | 8.62 | 295.62 | 31.81 | 125.27 | |
| Current deferred tax assets | 46.91 | 66.76 | 86.36 | 62.84 | |
| Short term receivables total | 8.62 | 342.54 | 98.56 | 86.36 | 188.11 |
| Other current investments | 2 044.26 | 1 822.66 | 2 227.47 | 2 135.78 | 1 762.60 |
| Cash and bank deposits | 2 195.80 | 1 926.02 | 1 862.17 | 1 895.20 | 2 057.69 |
| Cash and cash equivalents | 4 240.07 | 3 748.68 | 4 089.64 | 4 030.98 | 3 820.29 |
| Balance sheet total (assets) | 8 098.69 | 6 991.21 | 5 088.99 | 4 717.53 | 4 008.40 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Asset revaluation reserve | 1 594.57 | 1 460.05 | |||
| Shares repurchased | 100.00 | 117.80 | 61.00 | 67.50 | 79.40 |
| Retained earnings | 3 349.56 | 5 249.92 | 5 045.06 | 4 819.47 | 4 429.61 |
| Profit of the financial year | 1 883.65 | - 504.70 | - 158.10 | - 310.45 | - 706.53 |
| Shareholders equity total | 7 052.78 | 6 448.07 | 5 072.97 | 4 701.51 | 3 927.48 |
| Provisions | 449.75 | 166.89 | |||
| Non-current liabilities total | |||||
| Current trade creditors | 15.00 | 15.00 | 15.00 | 15.00 | 30.63 |
| Current owed to participating | 274.74 | 359.58 | 1.02 | 1.02 | 50.30 |
| Short-term deferred tax liabilities | 303.12 | ||||
| Other non-interest bearing current liabilities | 3.30 | 1.68 | |||
| Current liabilities total | 596.16 | 376.25 | 16.02 | 16.02 | 80.92 |
| Balance sheet total (liabilities) | 8 098.69 | 6 991.21 | 5 088.99 | 4 717.53 | 4 008.40 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated